CONTENTS OF SERUM MYOSTATIN IN TYPE 1 DIABETIC PATIENTS ASSOCIATED WITH AMOUNT OF MUSCLE MASS

被引：0
作者：
Shepelkevich, A. [1 ]
Dydyshka, Y. [1 ]
机构：
[1] Belarusian State Med Univ, Minsk, BELARUS
来源：
OSTEOPOROSIS INTERNATIONAL | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P539
引用
收藏
页码：S302 / S303
页数：2
相关论文
共 50 条
  • [31] Reduced muscle carnosine content in type 2, but not in type 1 diabetic patients
    Bruno Gualano
    Inge Everaert
    Sanne Stegen
    Guilherme Giannini Artioli
    Youri Taes
    Hamilton Roschel
    Eric Achten
    Maria Concepción Otaduy
    Antonio Herbert Lancha Junior
    Roger Harris
    Wim Derave
    Amino Acids, 2012, 43 : 21 - 24
  • [32] Relationship between Muscle Volume and Serum Myostatin Level in Patients with Heart Failure
    Suzuki, Tsuyoshi
    Shiga, Tsuyoshi
    Hagiwara, Nobuhisa
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S161 - S161
  • [33] Serum myostatin levels are associated with abdominal aortic calcification in dialysis patients
    Lee, Su Mi
    Kim, Seong Eun
    Lee, Ji Young
    Jeong, Hyo Jin
    Son, Young Ki
    An, Won Suk
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2019, 38 (04) : 481 - 489
  • [34] Serum adiponectin and progression of diabetic nephropathy in type 1 diabetic patients (The FinnDiane Study)
    Saraheimo, M. T.
    Forsblom, C.
    Thorn, L.
    Waden, J.
    Tolonen, N.
    Frystyk, J.
    Flyvbjerg, A.
    Groop, P.-H.
    DIABETOLOGIA, 2007, 50 : S114 - S115
  • [35] Glycosuria amount in response to hyperglycaemia and risk for diabetic kidney disease and related events in Type 1 diabetic patients
    Carpentier, Charlyne
    Dubois, Severine
    Mohammedi, Kamel
    Belhatem, Narimene
    Bouhanick, Beatrice
    Rohmer, Vincent
    Briet, Claire
    Bumbu, Anisoara
    Hadjadj, Samy
    Roussel, Ronan
    Potier, Louis
    Velho, Gilberto
    Marre, Michel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (10) : 1731 - 1738
  • [36] Human skeletal muscle THY1+fibro-adipogenic progenitors are associated with muscle degeneration in type 2 diabetic patients
    Farup, J.
    Just, J.
    de Paoli, F.
    Lin, L.
    Jensen, J. B.
    Billeskov, T.
    Comert, C.
    Moller, A. B.
    Madaro, L.
    Kampmann, U.
    Pedersen, S. B.
    Bross, P.
    Puri, P. L.
    Jessen, N.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 193 - 194
  • [37] Maternal history of type 2 diabetes is associated with diabetic nephropathy in type 1 diabetic patients
    Hadjadj, S.
    Duengler, F.
    Torremocha, F.
    Faure-Gerard, G.
    Bridoux, F.
    Boissonnot, M.
    Mauco, G.
    Guilhot, J.
    Marechaud, R.
    DIABETES & METABOLISM, 2007, 33 (01) : 37 - 43
  • [38] Plasma α-defensin is associated with diabetic nephropathy and mortality in type 1 diabetic patients
    Joseph, G.
    Tarnow, L.
    Hansen, T. K.
    Parving, H-H.
    Flyvbjerg, A.
    Frystyk, J.
    DIABETOLOGIA, 2006, 49 : 7 - 8
  • [39] SERUM URIC ACID IS NOT ASSOCIATED WITH DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES
    Gul, Cuma Bulent
    Yildiz, Abdulmecit
    Gul, Ozen Oz
    Hartavi, Mustafa
    Cander, Soner
    Eroglu, Ayca
    Keni, Nermin
    Bayindir, Aysenur
    Ersoy, Alparslan
    Ersoy, Canan
    ACTA MEDICA MEDITERRANEA, 2015, 31 (06): : 1153 - 1156
  • [40] Novel myostatin inhibitors increase muscle mass in wild-type and mdx mice
    Lachey, J.
    Pullen, A.
    Pearsall, R.
    Seehra, J.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 785 - 785
12345